A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients (Q86952639)
Jump to navigation
Jump to search
scientific article published on 01 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients |
scientific article published on 01 May 2015 |
Statements
A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients (English)
Gregory Bell
Saling Huang
Kevin J Martin
Geoffrey A Block